Solana Company (NASDAQ:HSDT) Short Interest Update

Solana Company (NASDAQ:HSDT) saw a significant increase in short interest in March. As of March 13th, there was short interest totaling 1,332,026 shares, an increase of 31.8% from the February 26th total of 1,010,452 shares. Approximately 3.9% of the shares of the stock are short sold. Based on an average trading volume of 329,865 shares, the short-interest ratio is currently 4.0 days.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Grant Private Wealth Management Inc bought a new stake in shares of Solana in the 4th quarter valued at about $46,000. Quattro Financial Advisors LLC bought a new position in Solana during the 4th quarter worth approximately $604,000. Franchise GP Ltd purchased a new position in Solana in the 4th quarter worth approximately $653,000. Geode Capital Management LLC bought a new stake in Solana in the fourth quarter valued at approximately $1,006,000. Finally, LPL Financial LLC boosted its stake in shares of Solana by 120.1% during the fourth quarter. LPL Financial LLC now owns 382,255 shares of the company’s stock valued at $1,105,000 after purchasing an additional 208,558 shares during the period. 18.63% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Solana in a report on Thursday, January 22nd. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Solana currently has an average rating of “Sell”.

Solana Stock Down 1.6%

Shares of HSDT stock traded down $0.03 during trading on Tuesday, hitting $1.83. The company had a trading volume of 648,449 shares, compared to its average volume of 442,493. The stock’s 50-day moving average is $2.26 and its two-hundred day moving average is $5.68. The stock has a market capitalization of $75.62 million, a price-to-earnings ratio of 0.00 and a beta of 1.08. Solana has a 52 week low of $1.63 and a 52 week high of $366.68.

Solana (NASDAQ:HSDT) last posted its quarterly earnings data on Monday, March 30th. The company reported $4.25 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($26.50) by $30.75. Solana had a negative net margin of 39,358.88% and a negative return on equity of 699.93%. The company had revenue of $5.23 million during the quarter, compared to the consensus estimate of $0.14 million.

About Solana

Helius Medical Technologies, Inc (NASDAQ: HSDT) is a medical technology company focused on developing and commercializing non‐invasive neuromodulation platforms designed to enhance neurorehabilitation. Its flagship product, the Portable Neuromodulation Stimulator (PoNS®), delivers mild electrical pulses to the tongue to stimulate neural pathways in conjunction with targeted physical therapy. The device is intended to improve neuroplasticity and support recovery in patients with neurological conditions.

The PoNS system is cleared for use in the United States, Canada and the European Union and is prescribed through specialized rehabilitation clinics.